PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-02 (1)

Date Title Company
02-Dec-2022 Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms of Agitation in Patients With Alzheimer’s Dementia at the 2022 Clinical Trials for Alzheimer’s Disease Congress Businesswire